Exploring High Growth Tech Stocks In Hong Kong October 2024

In This Article:

As global markets experience varied movements with U.S. indices reaching new highs and Chinese equities facing declines, the Hong Kong market is also navigating through a complex landscape influenced by broader economic sentiments and regional developments. In this context, identifying high growth tech stocks in Hong Kong requires a focus on companies that demonstrate resilience and adaptability to shifting market dynamics, leveraging innovation and strategic positioning to capture emerging opportunities.

Top 10 High Growth Tech Companies In Hong Kong

Name

Revenue Growth

Earnings Growth

Growth Rating

Wasion Holdings

22.37%

25.47%

★★★★★☆

MedSci Healthcare Holdings

48.74%

48.78%

★★★★★☆

Inspur Digital Enterprise Technology

25.31%

39.04%

★★★★★☆

RemeGen

26.30%

52.19%

★★★★★☆

Innovent Biologics

21.80%

59.60%

★★★★★☆

Akeso

33.44%

53.00%

★★★★★★

Cowell e Holdings

31.68%

35.44%

★★★★★★

Biocytogen Pharmaceuticals (Beijing)

21.53%

109.17%

★★★★★☆

Beijing Airdoc Technology

37.47%

93.35%

★★★★★☆

Sichuan Kelun-Biotech Biopharmaceutical

24.70%

8.53%

★★★★★☆

Click here to see the full list of 43 stocks from our SEHK High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Plover Bay Technologies

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Plover Bay Technologies Limited is an investment holding company that designs, develops, and markets software-defined wide area network routers, with a market capitalization of HK$5.34 billion.

Operations: The company generates revenue primarily from the sales of software-defined wide area network routers, with notable contributions from both fixed first connectivity (HK$15.19 million) and mobile first connectivity (HK$59.87 million). Additionally, it earns through software licenses and warranty and support services, amounting to HK$31.86 million.

Plover Bay Technologies has demonstrated robust financial performance, with a significant uptick in sales from USD 44.63 million to USD 57.3 million, marking a year-over-year increase of about 28%. This growth is complemented by an earnings surge from USD 12.32 million to USD 19.1 million. Notably, the company's strategic focus on R&D is evident as it aligns with its revenue growth forecasts at an impressive rate of 16.9% annually, outpacing the Hong Kong market's average of 7.3%. The appointment of Ms. Chiu Chi Ying as an executive Director could further enhance governance and innovation strategies, particularly in legal and intellectual property realms crucial for sustaining competitive advantages in high-tech industries.